163 related articles for article (PubMed ID: 15912818)
1. [Change in the point of view].
Krankenpfl J; 2005; 43(1-3):23-4. PubMed ID: 15912818
[No Abstract] [Full Text] [Related]
2. [Duloxetine reduces pain and depression].
Krankenpfl J; 2004; 42(7-10):246-7. PubMed ID: 15675408
[No Abstract] [Full Text] [Related]
3. [Duloxetine receives positive recommendation by the Scientific Committee of EMEA for treatment of depression].
Krankenpfl J; 2004; 42(7-10):247. PubMed ID: 15675409
[No Abstract] [Full Text] [Related]
4. [Physical complaints can overlap mental symptoms. Diffuse pain? Think about depression!].
MMW Fortschr Med; 2006 Jun; 148(23):62. PubMed ID: 16826743
[No Abstract] [Full Text] [Related]
5. [Duloxetin effective in depression and pain: high remission rates obtained].
MMW Fortschr Med; 2006 Jun; 148(23):63. PubMed ID: 16826744
[No Abstract] [Full Text] [Related]
6. Successful duloxetine treatment of a binge eating disorder: a case report.
Bernardi S; Pallanti S
J Psychopharmacol; 2010 Aug; 24(8):1269-72. PubMed ID: 19010975
[TBL] [Abstract][Full Text] [Related]
7. [FDA approval for the antidepressive drug Cymbalta].
Krankenpfl J; 2004; 42(5-6):154. PubMed ID: 15527218
[No Abstract] [Full Text] [Related]
8. [Psycho- and pharmacotherapy of depressions. So you combine correctly].
Arnheim K
MMW Fortschr Med; 2009 May; 151(19):20. PubMed ID: 19827439
[No Abstract] [Full Text] [Related]
9. Intensive monitoring of duloxetine: results of a web-based intensive monitoring study.
Härmark L; van Puijenbroek E; van Grootheest K
Eur J Clin Pharmacol; 2013 Feb; 69(2):209-15. PubMed ID: 22688722
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects.
Turcotte JE; Debonnel G; de Montigny C; Hébert C; Blier P
Neuropsychopharmacology; 2001 May; 24(5):511-21. PubMed ID: 11282251
[TBL] [Abstract][Full Text] [Related]
11. Duloxetine: an innovative approach for treating stress urinary incontinence.
Van Kerrebroeck P
BJU Int; 2004 Jul; 94 Suppl 1():31-7. PubMed ID: 15139861
[No Abstract] [Full Text] [Related]
12. Regarding "Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind randomized study": Optimizing initial interventions.
Farber GA; Goldberg JF
Biol Psychiatry; 2004 Oct; 56(7):535; author reply 535-6. PubMed ID: 15450792
[No Abstract] [Full Text] [Related]
13. Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive disorder.
Schatzberg AF
J Clin Psychiatry; 2003; 64 Suppl 13():30-7. PubMed ID: 14552654
[TBL] [Abstract][Full Text] [Related]
14. Effects of duloxetine on painful physical symptoms associated with depression.
Goldstein DJ; Lu Y; Detke MJ; Hudson J; Iyengar S; Demitrack MA
Psychosomatics; 2004; 45(1):17-28. PubMed ID: 14709757
[TBL] [Abstract][Full Text] [Related]
15. Duloxetine: a review of its pharmacology and use in chronic pain management.
Bellingham GA; Peng PW
Reg Anesth Pain Med; 2010; 35(3):294-303. PubMed ID: 20921842
[TBL] [Abstract][Full Text] [Related]
16. Initial duloxetine prescription dose and treatment adherence and persistence in patients with major depressive disorder.
Liu X; Gelwicks S; Faries DE; Able SL
Int Clin Psychopharmacol; 2010 Nov; 25(6):315-22. PubMed ID: 20706125
[TBL] [Abstract][Full Text] [Related]
17. Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.
Lam RW; Lönn SL; Despiégel N
Int Clin Psychopharmacol; 2010 Jul; 25(4):199-203. PubMed ID: 20357664
[TBL] [Abstract][Full Text] [Related]
18. Is there a place for duloxetine?
Drug Ther Bull; 2007 Apr; 45(4):29-32. PubMed ID: 17451072
[TBL] [Abstract][Full Text] [Related]
19. Switching from serotonin reuptake inhibitors to duloxetine in patients with resistant obsessive compulsive disorder: a case series.
Dell'osso B; Mundo E; Marazziti D; Altamura AC
J Psychopharmacol; 2008 Mar; 22(2):210-3. PubMed ID: 18208931
[TBL] [Abstract][Full Text] [Related]
20. Biological perspectives. Serotonin and norepinephrine reuptake inhibitors (SNRIs): venlafaxine and duloxetine.
Lee SI; Keltner NL
Perspect Psychiatr Care; 2006 May; 42(2):144-8. PubMed ID: 16677140
[No Abstract] [Full Text] [Related]
[Next] [New Search]
